157 related articles for article (PubMed ID: 32378800)
1. Interaction of FGF9 with FGFR3-IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma.
Paur J; Valler M; Sienel R; Taxauer K; Holzmann K; Marian B; Unterberger A; Mohr T; Berger W; Gvozdenovich A; Schimming J; Grusch M; Grasl-Kraupp B
Liver Int; 2020 Sep; 40(9):2279-2290. PubMed ID: 32378800
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?
Paur J; Nika L; Maier C; Moscu-Gregor A; Kostka J; Huber D; Mohr T; Heffeter P; Schrottmaier WC; Kappel S; Kandioler D; Holzmann K; Marian B; Berger W; Grusch M; Grasl-Kraupp B
Hepatology; 2015 Dec; 62(6):1767-78. PubMed ID: 26235436
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma.
Seitz T; Freese K; Dietrich P; Thasler WE; Bosserhoff A; Hellerbrand C
Sci Rep; 2020 Mar; 10(1):4546. PubMed ID: 32161315
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines.
Asada N; Tanaka Y; Hayashido Y; Toratani S; Kan M; Kitamoto M; Nakanishi T; Kajiyama G; Chayama K; Okamoto T
In Vitro Cell Dev Biol Anim; 2003; 39(7):321-8. PubMed ID: 14753849
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.
Murgue B; Tsunekawa S; Rosenberg I; deBeaumont M; Podolsky DK
Cancer Res; 1994 Oct; 54(19):5206-11. PubMed ID: 7923141
[TBL] [Abstract][Full Text] [Related]
6. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
7. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.
Correa D; Somoza RA; Lin P; Greenberg S; Rom E; Duesler L; Welter JF; Yayon A; Caplan AI
Osteoarthritis Cartilage; 2015 Mar; 23(3):443-53. PubMed ID: 25464167
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines.
Tomlinson DC; L'Hôte CG; Kennedy W; Pitt E; Knowles MA
Cancer Res; 2005 Nov; 65(22):10441-9. PubMed ID: 16288035
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
Gauglhofer C; Paur J; Schrottmaier WC; Wingelhofer B; Huber D; Naegelen I; Pirker C; Mohr T; Heinzle C; Holzmann K; Marian B; Schulte-Hermann R; Berger W; Krupitza G; Grusch M; Grasl-Kraupp B
Carcinogenesis; 2014 Oct; 35(10):2331-8. PubMed ID: 25031272
[TBL] [Abstract][Full Text] [Related]
10. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
Chen G; Wang J; Liu Z; Kornmann M
Pancreas; 2008 Aug; 37(2):159-64. PubMed ID: 18665077
[TBL] [Abstract][Full Text] [Related]
11. Targeting the extracellular domain of fibroblast growth factor receptor 3 with human single-chain Fv antibodies inhibits bladder carcinoma cell line proliferation.
Martínez-Torrecuadrada J; Cifuentes G; López-Serra P; Saenz P; Martínez A; Casal JI
Clin Cancer Res; 2005 Sep; 11(17):6280-90. PubMed ID: 16144932
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.
Liu X; Jing X; Cheng X; Ma D; Jin Z; Yang W; Qiu W
Med Oncol; 2016 May; 33(5):46. PubMed ID: 27044356
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.
Kettunen P; Karavanova I; Thesleff I
Dev Genet; 1998; 22(4):374-85. PubMed ID: 9664689
[TBL] [Abstract][Full Text] [Related]
14. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.
Hecht D; Zimmerman N; Bedford M; Avivi A; Yayon A
Growth Factors; 1995; 12(3):223-33. PubMed ID: 8619928
[TBL] [Abstract][Full Text] [Related]
15. Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells.
Koneczny I; Schulenburg A; Hudec X; Knöfler M; Holzmann K; Piazza G; Reynolds R; Valent P; Marian B
Mol Carcinog; 2015 Sep; 54(9):789-799. PubMed ID: 24619956
[TBL] [Abstract][Full Text] [Related]
16. Human RPE cells express the FGFR2IIIc and FGFR3IIIc splice variants and FGF9 as a potential high affinity ligand.
Alizadeh M; Miyamura N; Handa JT; Hjelmeland LM
Exp Eye Res; 2003 Feb; 76(2):249-56. PubMed ID: 12565813
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.
Yin Y; Ren X; Smith C; Guo Q; Malabunga M; Guernah I; Zhang Y; Shen J; Sun H; Chehab N; Loizos N; Ludwig DL; Ornitz DM
Dis Model Mech; 2016 May; 9(5):563-71. PubMed ID: 27056048
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.
Gauglhofer C; Sagmeister S; Schrottmaier W; Fischer C; Rodgarkia-Dara C; Mohr T; Stättner S; Bichler C; Kandioler D; Wrba F; Schulte-Hermann R; Holzmann K; Grusch M; Marian B; Berger W; Grasl-Kraupp B
Hepatology; 2011 Mar; 53(3):854-64. PubMed ID: 21319186
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
Amann T; Bataille F; Spruss T; Dettmer K; Wild P; Liedtke C; Mühlbauer M; Kiefer P; Oefner PJ; Trautwein C; Bosserhoff AK; Hellerbrand C
Am J Pathol; 2010 Mar; 176(3):1433-42. PubMed ID: 20093481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
